Precision BioSciences, Inc announced a definitive subscription agreement in a non-brokered private placement of 25,000 shares, par value $0.000005 per share at an offering price of $12 per share for a gross proceeds $300,000 on May 8, 2024. The transaction included participation from Michael Amoroso, Alex Kelly, Dario Scimeca and Jeff Smith. Michael Amoroso, President and Chief Executive Officer of the Company and a member of the Company?s board of directors, who agreed to purchase 8,334 Shares for an aggregate amount of $100,008, Alex Kelly, Chief Financial Officer of the Company, who agreed to purchase 8,334 Shares for an aggregate amount of $100,008, Dario Scimeca, General Counsel of the Company, who agreed to purchase 833 Shares for an aggregate amount of $9,996; and Jeff Smith, Chief Research Officer of the Company, who agreed to purchase 833 Shares for an aggregate amount of $9,996.